| 英文别名： |
oxymetholone--dea schedule iii;7-alpha-Methyl-2-hydroxymethylene-17-hydroxy-5-alpha-androstan-3-one;17-beta-androstan-3-one,17-hydroxy-2-(hydroxymethylene)-17-methyl-5-alph;17-beta-Hydroxy-2-(hydroxymethylene)-17-alpha-methyl-5-alpha-androstan-3-one;17-beta-hydroxy-2-(hydroxymethylene)-17-methyl-5-alpha-androstan-3-on;17beta-hydroxy-2-(hydroxymethylene)-17-methyl-5alpha-androstan-3-on;17-beta-Hydroxy-2-hydroxymethylene-17-alpha-methyl-3-androstanone;17-hydroxy-2-(hydroxymethylene)-17-methyl-,(alpha,17beta)-androstan-3-on;17-Hydroxy-2-(hydroxymethylene)-17-methyl-5-alpha-17-beta-androst-3-one;Oxymetholone;Oxymetholone(Anadrol);Anadrol knight labs;17β-Hydroxy-2-(hydroxymethylene)-17-methyl-5α-androstan-3-one;Adroidin;Adroyd;Anadrol;Anadroyd;Becorel;Raboral;Roboral;Stanozolol impurity B;Anasterone;17b-Hydroxy-2-hydroxymethylene-17a-methyl-3-androstanone;4,5-Dihydro-2-hydroxymethylene-17-a-methyltestosterone;Protanabol;Oximetolona;Nastenon;Oxymethenolone;Oxymetholonum;Oxymethalone;Anapolon;Synasteron;Plenastril;Anasteron;Oximetholonum;Oximetalonu;Dynasten;Pavisoid;Zenalosyn;Methabol;Ossimetolone [DCIT];Anasteronal;Oximetolona [INN-Spanish];Oxymetholonum [INN-Latin];CI 406;17-Hydroxy-5-alpha-androstan-3-one;2-Hydroxymethylene-;Anapolon 50;Oximetholone;NSC-2;Oxymethenolone/ anadrol |
沪公网安备31011402010658号 
